(907) 267-5890
Advanced Dermatology of Alaska logo
Back to all articles
Advanced Dermatology of Alaska

Skin Cancer · Patient Guide

Your Biopsy Shows Basal Cell or Squamous Cell Carcinoma: What Happens Next?

What your pathology report means, what to gather, how treatment is chosen, and how to schedule care at our Anchorage, Wasilla, and Juneau clinics, including for patients from Palmer and the Mat-Su Valley.

By Advanced Dermatology of Alaska · November 15, 2026

Your biopsy results are back, and they show basal cell carcinoma or squamous cell carcinoma. It is normal to feel worried. These are the two most common skin cancers, and the news is usually better than the word "cancer" suggests.

As dermatologists in Anchorage, Wasilla, and Juneau, we help patients through this step every week. This guide explains what your pathology report means, why it is best not to wait, what to gather, how treatment is chosen, and how to schedule care with us.

First, take a breath

A skin cancer diagnosis is serious, and it deserves prompt care. It also helps to know what you are facing:

This guide covers basal cell and squamous cell carcinoma. If your biopsy shows melanoma, your dermatologist will explain your results and next steps, which may include surgery to remove it and, when needed, referral to other specialists.

What your pathology report tells you

After your biopsy, a dermatopathologist, a physician who specializes in both dermatology and pathology, examined the sample under a microscope and wrote a report (American Academy of Dermatology). Your report may include:

  • The type of cancer, such as basal cell carcinoma or squamous cell carcinoma.
  • A subtype or growth pattern. For basal cell carcinoma, an aggressive growth pattern under the microscope puts the cancer in a higher-risk group (American Cancer Society).
  • Whether the cancer is in situ or invasive. In situ means the cancer cells are only in the top layer of the skin. Invasive means they have grown deeper.
  • Nerve involvement. If cancer cells have grown into small nerves in or near the tumor, the report may call this perineural invasion, which is a higher-risk feature (American Cancer Society).
  • A comment on the margins, which are the edges of the biopsy sample.

Low-risk and high-risk basal cell carcinoma

Doctors sort basal cell carcinomas into low-risk and high-risk groups, based on how likely they are to come back after treatment. A basal cell carcinoma is high risk if any of these apply (American Cancer Society):

  • It is on the head, neck, hands, feet, front of the lower leg, or genital area, of any size, or it is at least 2 cm across on the trunk, arm, or leg
  • Its borders are not well defined
  • It has come back after earlier treatment
  • It is in a place that was treated with radiation before
  • It has an aggressive growth pattern under the microscope
  • It has grown into small nerves (perineural invasion)
  • The person has a weakened immune system

What margins mean

Sometimes the biopsy removes the whole cancer. If the biopsy removes the entire tumor, that is often enough to cure basal cell carcinoma without further treatment (American Cancer Society).

A report that says the margins are clear or negative is not a guarantee, though. The lab looks at only about 1 to 2 percent of a biopsy's edges. In one study of 143 basal cell carcinoma biopsies reported with negative margins, 34 (24 percent) still had cancer in the skin when the area was later removed (Journal of the American Academy of Dermatology). A review of four studies found cancer left behind in about 13 percent of squamous cell carcinomas and 28 percent of basal cell carcinomas whose shave biopsies had been reported with negative margins (Dermatologic Surgery).

That is why your dermatologist looks at the whole report, the location of the cancer, and your health before recommending treatment, even when the biopsy site has healed and looks normal.

Why it is best not to wait

Basal cell carcinoma can grow deep, so it is best to treat it early. When it is left untreated, it continues to grow, and it can reach into muscle and bone (American Academy of Dermatology).

Left untreated, squamous cell carcinoma may grow deep and spread. Waiting to get care gives it time to grow, which can make treatment more difficult, so dermatologists recommend getting treated as soon as possible after diagnosis (American Academy of Dermatology).

Waiting also makes the biopsy site harder to find. Patients were more likely to point to the wrong spot when 6 weeks or more passed between the biopsy and surgery, or when the site was somewhere they could not see (Journal of the American Academy of Dermatology).

What to gather before your next appointment

  1. A copy of your pathology report. If your biopsy was done at another office, have that office send the report to us before your visit.
  2. A photo of the biopsy site. Biopsy sites can heal fast and become hard to see.
  3. Your medication list, including blood thinners, aspirin, and supplements. Do not stop a prescription blood thinner on your own. Your care team will tell you what to do before any procedure.
  4. Your insurance cards and a photo ID.
  5. A referral, if your insurance plan requires one. We do not require a referral to request an appointment.

Please do not send photos or medical records through our website forms. Call (907) 267-5890, and our team will tell you how to send them securely.

How your treatment is chosen

There is no single best treatment for every skin cancer. For basal cell carcinoma, your dermatologist considers how deeply the cancer has grown, where it is on your body, your health and age, whether it is new or has come back after treatment, and which treatment will give you the best outcome (American Academy of Dermatology). Dermatologists also use appropriate use criteria, which rated 270 clinical scenarios to identify when Mohs surgery offers the most benefit (Journal of the American Academy of Dermatology).

Treatment options

Depending on your cancer and your health, options can include (American Academy of Dermatology; American Academy of Dermatology):

  • Mohs surgery, which removes the cancer one thin layer at a time and checks the edges under a microscope while you wait. Mohs is especially helpful for cancers in certain locations, cancers with borders that are hard to see, and cancers that have come back.
  • Surgical excision, which cuts out the cancer with a margin of normal-looking skin.
  • Electrodesiccation and curettage, which scrapes away the cancer and treats the area with an electric needle. It may be a good option for basal cell carcinomas that are confined to the top layer of skin and have a low risk of coming back (American Cancer Society).
  • Radiation therapy, including GentleCure image-guided superficial radiation therapy (IGSRT), a nonsurgical option for some basal cell and squamous cell skin cancers, offered at our Wasilla clinic. Read our comparison of GentleCure and Mohs surgery.
  • Other options for some cancers, such as a prescription medicine applied to the skin, photodynamic therapy, or freezing (cryosurgery).

Mohs surgery is not right for every skin cancer. Your dermatologist will explain the trade-offs of each option, including cure rates, recovery, and scarring, so you can decide together.

Scheduling treatment with us

Our board-certified dermatologists and SDPA Dermatology Trained physician assistants diagnose and treat skin cancer at all three of our clinics. Double board-certified Mohs surgeon Andrew S. Dorizas, MD, FAAD, performs Mohs surgery at each one, and reconstruction is coordinated with a board-certified plastic and reconstructive surgeon when it is needed. Same-week appointments are available, and our team will help you schedule your consultation or treatment.

Anchorage

Our Anchorage clinic at 1100 E Dimond Blvd, Anchorage, AK 99515, offers skin cancer care and Mohs surgery, and serves patients from Eagle River, Chugiak, and the rest of the Anchorage area.

Wasilla, Palmer, and the Mat-Su Valley

Our Wasilla clinic at 3066 E Meridian Park Loop, Wasilla, AK 99654, offers skin cancer care, Mohs surgery, and GentleCure image-guided superficial radiation therapy, and serves patients from Palmer and across the Mat-Su Valley.

Juneau

Our Juneau clinic is inside Bartlett Regional Hospital Specialty Clinics at 3268 Hospital Drive, Juneau, AK 99801. Mohs surgery is offered there on scheduled clinic dates each month. Call (907) 267-5890 to ask about upcoming dates.

If Mohs surgery is recommended, read our Mohs surgery patient guide to learn how to prepare and what to expect.

Questions to ask your dermatologist

  • What type and subtype of skin cancer do I have?
  • Is it low risk or high risk?
  • Did the biopsy remove all of it?
  • What are my treatment options, and what is the cure rate of each?
  • Do you recommend Mohs surgery for this cancer? Why or why not?
  • What will the scar look like, and will I need stitches or a repair?
  • How long is recovery, and are there activities I should avoid?
  • How often should I have skin checks after treatment?

Insurance and referrals

We are in-network with all major insurance plans, commercial and government, and we check your benefits before surgery. We do not require a referral to request an appointment, but some insurance plans do. Learn more on our insurance page. Physicians and other clinicians can find referral information on our page for referring providers.

After treatment: why follow-up matters

If you have had any type of skin cancer, you have a greater risk of developing another one (American Academy of Dermatology). At some point after your diagnosis, you will need a full-body skin exam to check for other spots that could be skin cancer (American Academy of Dermatology).

For warning signs, self-exam steps, and sun protection tips for Alaska, read our skin cancer in Alaska patient guide.

We are here to help

Just got your biopsy results? Call us at (907) 267-5890 or request an appointment online.

Serving Wasilla, Palmer, Anchorage, Juneau & the Mat-Su Valley

Frequently asked questions

QR code linking to this biopsy results patient guide

Scan to revisit this page

Point your phone camera here to reopen this guide anytime.

Medical disclaimer

This guide was prepared by the dermatology team at Advanced Dermatology of Alaska using information from the American Academy of Dermatology, the American Cancer Society, the American College of Mohs Surgery, and peer-reviewed medical research. This guide is for general education and does not replace individualized medical care. This page reflects information as of November 15, 2026. For advice about your own skin and your own pathology report, contact your healthcare provider.

Selected references

  1. American Academy of Dermatology. Basal cell carcinoma: From symptoms to treatments. Updated October 1, 2025.
  2. American Academy of Dermatology. Squamous cell carcinoma: From symptoms to treatments. Updated January 13, 2026.
  3. American Cancer Society. Early detection, diagnosis, and staging of basal cell carcinoma. Revised August 11, 2026.
  4. American Cancer Society. Stages and risk groups of basal cell carcinoma. Revised August 11, 2026.
  5. American Cancer Society. Surgery for basal cell carcinoma. Revised August 11, 2026.
  6. American Academy of Dermatology. What is a skin biopsy?
  7. American College of Mohs Surgery. Post-Operative Care.
  8. Willardson HB, Lombardo J, Raines M, et al. Predictive value of basal cell carcinoma biopsies with negative margins: a retrospective cohort study. J Am Acad Dermatol. 2018;79(1):42-46.
  9. Purnell JC, Duncan JR, Stratton MS, et al. Negative predictive value of biopsy margins in keratinocyte carcinoma: a literature review. Dermatol Surg. 2020;46(4):525-529.
  10. McGinness JL, Goldstein G. The value of preoperative biopsy-site photography for identifying cutaneous lesions. Dermatol Surg. 2010;36(2):194-197.
  11. Zhang J, Rosen A, Orenstein L, et al. Factors associated with biopsy site identification, postponement of surgery, and patient confidence in a dermatologic surgery practice. J Am Acad Dermatol. 2016;74(6):1185-1193.
  12. Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery. J Am Acad Dermatol. 2012;67(4):531-550.
  13. van Loo E, Mosterd K, Krekels GA, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011-3020.